Feature Channels: Vaccines

Filters close
14-Jun-2022 11:15 AM EDT
Factors Causing Low Covid-19 Vaccination Have Spilled Over to Lower Flu Vaccination Rates
University of California, Los Angeles (UCLA), Health Sciences

A new study from UCLA researchers indicates a previously undocumented impact of the promotion of Covid-19 vaccines on other public health behaviors. Adult flu vaccination rates have declined in states with low rates of Covid-19 vaccination, which the authors say may be a harbinger of declining trust in public health and could make some populations more vulnerable to preventable disease.

Newswise: UTSW Infectious Diseases Experts Offer Advice on Second COVID-19 Booster
Released: 15-Jun-2022 1:20 PM EDT
UTSW Infectious Diseases Experts Offer Advice on Second COVID-19 Booster
UT Southwestern Medical Center

Individuals should weigh their own personal health and risk levels in deciding when to receive a second booster of the COVID-19 vaccine, UT Southwestern infectious diseases experts advise.

Released: 15-Jun-2022 9:55 AM EDT
Who Should Get Vaccinated First Where Supplies Are Limited? It Depends.
Rutgers University-New Brunswick

Prioritizing older residents for COVID-19 vaccination may not make sense for all nations, a Rutgers analysis finds

Released: 14-Jun-2022 4:05 PM EDT
Omicron Hit Rural America Harder Than Cities
University of Cincinnati

The omicron wave of the COVID-19 pandemic in late 2021 and early 2022 spread like a grass fire in America’s densely populated cities but led to higher rates of death in rural counties where vaccinations are lagging.

Released: 13-Jun-2022 11:35 AM EDT
Study: Text Messaging Shows Promise in Reaching Unvaccinated Patients
Perelman School of Medicine at the University of Pennsylvania

While automated texting did not get more patients to get their vaccinations against COVID-19, it reached roughly the same amount as manned phone calls

   
9-Jun-2022 12:40 PM EDT
Mount Sinai Researchers Develop a Rapid Test to Measure Immunity to COVID-19
Mount Sinai Health System

Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone’s immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring of the population’s immunity and the effectiveness of current vaccines to help design revaccination strategies for vulnerable immunosuppressed individuals, according to a study published in Nature Biotechnology in June.

7-Jun-2022 10:05 AM EDT
COVID-19 vaccination appears to be safe for patients treated for hypothyroidism
Endocrine Society

Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism, according to a new study being presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga. The study found these vaccines do not cause significant fluctuations in thyroid function and are not associated with increased risks of emergency department visits or unscheduled hospitalizations.

Newswise: UTSW’s Medical Student Group named Texas Medical Association Chapter of the Year
Released: 10-Jun-2022 12:35 PM EDT
UTSW’s Medical Student Group named Texas Medical Association Chapter of the Year
UT Southwestern Medical Center

A student group at UT Southwestern Medical School has been named the 2022 Chapter of the Year by the Texas Medical Association Medical Student Section.

Newswise: Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
9-Jun-2022 12:05 AM EDT
Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
McMaster University

McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

Released: 9-Jun-2022 3:00 PM EDT
The Effect of Fear of Infection and Sufficient Vaccine Reservation Information on Rapid COVID-19 Vaccination in Japan: Evidence From a Retrospective Twitter Analysis
Journal of Medical Internet Research

Background: The global public health and socioeconomic impacts of the COVID-19 pandemic have been substantial, rendering herd immunity by COVID-19 vaccination an important factor for protecting people and retrieving the economy. Amon...

6-Jun-2022 5:35 PM EDT
COVID-19 Vaccine Incentives Get Mixed Reception From Young People
Michigan Medicine - University of Michigan

Offering teens and young adults a chance at a college scholarship, cash, discounts or just some free food might help move the needle on COVID-19 vaccination rates, a new study suggests. In all, 82% of people between the ages of 14 and 24 have a positive attitude toward prizes, raffles, giveaways, and other incentives designed to increase vaccination. But a sizable minority of young people have their doubts about whether such vaccine incentives will work or are ethical.

Released: 8-Jun-2022 10:05 AM EDT
Casos crescentes de varíola dos macacos são investigados
Mayo Clinic

Cientistas de todo o mundo estão investigando vários grupos de casos de varíola dos macacos relatados em 12 países (incluindo um caso confirmado e um suspeito nos EUA) .

Newswise: Roswell Park-Developed Immunotherapy Now Part of Nationwide Study in Kids With Brain Cancer
Released: 7-Jun-2022 2:05 PM EDT
Roswell Park-Developed Immunotherapy Now Part of Nationwide Study in Kids With Brain Cancer
Roswell Park Comprehensive Cancer Center

The immunotherapy SurVaxM is being utilized in a pilot study in children and adolescents with several brain cancer types through a multicenter trial sponsored by the Pediatric Brain Tumor Consortium (PBTC).

6-Jun-2022 11:00 AM EDT
Risk of Breakthrough COVID-19 Infection after Vaccination Is Higher Among People with HIV
Johns Hopkins Bloomberg School of Public Health

Finding suggests that all people with HIV might benefit from additional dose in primary vaccination.

Newswise: Causes of Liver Cancer are Changing Around the World: Some Up, Some Down
Released: 6-Jun-2022 2:05 PM EDT
Causes of Liver Cancer are Changing Around the World: Some Up, Some Down
UC San Diego Health

UC San Diego researchers report that the causes and death rates of liver cancer are changing around the world.

Newswise: Path to Remission for a Brain Cancer That Is Usually Fatal
Released: 6-Jun-2022 11:05 AM EDT
Path to Remission for a Brain Cancer That Is Usually Fatal
Cedars-Sinai

Recently, Michael Wulfe, who is 61 and lives in West Hollywood, was on the phone with his sister, Stephanie Wulfe, in Dallas. They talk at least once a day, but that day, something wasn’t right. “I was talking, and then I didn’t have the words,” Wulfe said. “My sister immediately said, ‘Call Cedars-Sinai!’”

Released: 3-Jun-2022 2:00 PM EDT
Monkeypox is not shingles and there is no evidence that the Monkeypox outbreak has anything to do with the COVID-19 vaccines
Newswise

The claim that the available COVID-19 vaccines are behind the monkeypox outbreak, and that monkeypox is basically shingles, which they claim is a side effect of the vaccines, is entirely false.

Newswise: Vaccines have up to 90% efficacy against severe COVID-19 for up to six months
Released: 2-Jun-2022 9:30 AM EDT
Vaccines have up to 90% efficacy against severe COVID-19 for up to six months
Penn State College of Medicine

Protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19 remains high for about six months, according to a recent study by Penn State College of Medicine scientists.

25-May-2022 11:20 AM EDT
Vaccination Protects Patients on Dialysis From Severe COVID-19
American Society of Nephrology (ASN)

In a study of individuals on hemodialysis who tested positive for SARS-CoV-2, most had a mild course of COVID-19, but 39%were hospitalized and 13% died.

Released: 1-Jun-2022 1:05 AM EDT
Study Finds Conversion Messages Effective in Reaching Vaccine-Hesitant Populations
University of Kansas

Health communicators, medical professionals, politicians and even average citizens have struggled with ways to convince those hesitant about COVID-19 vaccines to get inoculated.

Released: 31-May-2022 5:05 PM EDT
International study reveals factors contributing to COVID-19 vaccine hesitancy among healthcare providers
Elsevier

A new 23-country study by a multidisciplinary team of researchers in the journal Vaccine, published by Elsevier, sheds light on the factors that contribute to COVID-19 vaccine hesitancy among healthcare providers.

Newswise: LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
Released: 31-May-2022 2:05 PM EDT
LJI scientists publish first head-to-head comparison of four COVID-19 vaccines
La Jolla Institute for Immunology

"Just understanding the immune responses to these vaccines will help us integrate what is successful into vaccine designs going forward.”

Released: 31-May-2022 12:35 PM EDT
Americans More Likely to Seek Surgical Care During a Pandemic if They and Hospital Staff are Vaccinated
American Society of Anesthesiologists (ASA)

Americans are more likely to have surgery during a pandemic such as COVID-19 if they are vaccinated, the hospital staff are vaccinated, the surgery is urgent or lifesaving (as opposed to elective), and the surgery is outpatient (i.e., not requiring an overnight stay), according to a new study published in Vaccine.

   
Released: 27-May-2022 5:05 PM EDT
Previous COVID-19 or MIS-C does not protect kids from Omicron
Boston Children's Hospital

Research drawing on the national Overcoming COVID-19 study, led by Boston Children’s Hospital, and the hospital’s own Taking On COVID-19 Together Group provides evidence that children who previously had COVID-19 (or the inflammatory condition MIS-C) are not protected against the newer Omicron variant.

26-May-2022 5:05 PM EDT
Study: More equitable vaccine coverage could have prevented over 250 COVID-19 deaths in Chicago
University of Chicago Medical Center

University of Chicago Medicine research shows discrepancies in COVID-19 vaccine coverage across Chicago zip codes.

Newswise: What Do We Know – and Need to Know - About Monkeypox?
Released: 26-May-2022 5:05 PM EDT
What Do We Know – and Need to Know - About Monkeypox?
UCLA Fielding School of Public Health

Q&A about monkeypox with Dr. Anne Rimoin, UCLA Fielding School of Public Health professor of epidemiology and the Gordon-Levin Endowed Chair in Infectious Diseases and Public Health, has been studying monkeypox for two decades.

Released: 26-May-2022 7:30 AM EDT
An alarming prevalence of smell, taste loss during COVID’s delta surge
Ohio State University

The loss of smell and taste with a COVID-19 infection during the delta surge was a prevalent symptom and wasn’t prevented by vaccination, new research suggests. The study also found some people with the earliest COVID infections had loss of these senses months later and didn’t even realize it.

Released: 25-May-2022 5:30 PM EDT
Protein nanoparticle vaccine shows potential for broader, safe SARS-CoV-2 vaccines, biomedical sciences researchers find
Georgia State University

A nanoparticle vaccine that combines two proteins that induce immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that has caused the global pandemic, has the potential to be developed into broader and safe SARS-CoV-2 vaccines, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

Released: 25-May-2022 4:35 PM EDT
Study shows that vaccinated individuals develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than the unvaccinated after an Omicron infection
University of Hong Kong

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of Medicine, The Chinese University of Hong Kong (CU Medicine) shows that vaccinated individuals can develop more robust and broadly reactive antibody responses against SARS-CoV-2 variants than unvaccinated individuals after an Omicron infection.

Released: 25-May-2022 1:15 PM EDT
Why COVID Vaccines Are Deemed Non-Essential for UK Young Children
University of Huddersfield

Throughout the pandemic the University of Huddersfield’s Department of Pharmacy has been raising awareness on what vaccines are, how they are formulated, and why they're an important part of the healthcare strategy as well as the progress on further developments in COVID vaccines, so that people can make an educated decision on becoming vaccinated or if choosing for their children.

23-May-2022 1:05 PM EDT
Long COVID Poses Risks to Vaccinated People, Too
Washington University in St. Louis

Vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System. However, a new study of more than 13 million veterans also found that vaccination against the virus that causes COVID-19 reduced the risk of death by 34% and the risk of getting long COVID-19 by 15%, compared with unvaccinated patients infected with the virus.

Released: 24-May-2022 5:25 PM EDT
COVID vaccine trial locations influenced in vaccine efficacy results
University of Arkansas, Fayetteville

A new study by a University of Arkansas information systems researcher and his colleague at the University of Waikato in New Zealand shows that COVID vaccine trials conducted in geographic locations with low infection rates had higher efficacy results, compared to trials in locations with high infection rates.

18-May-2022 2:15 PM EDT
Data contradict fears of COVID-19 vaccine effects on pregnancy and fertility
PLOS

Study adds further evidence that vaccination is protective and safer than COVID-19 infection.

Newswise: Study: Medicine for Inflammatory Bowel Disease May Protect Against Severe COVID-19
Released: 23-May-2022 10:05 AM EDT
Study: Medicine for Inflammatory Bowel Disease May Protect Against Severe COVID-19
Cedars-Sinai

Getting the COVID-19 vaccination strengthened one type of immune response to the SARS-CoV-2 virus in inflammatory bowel disease (IBD) patients even though they were taking immunosuppressant medication, according to investigators at Cedars-Sinai.

Released: 19-May-2022 4:35 PM EDT
Study shines light on longevity of COVID-19 immune response
American Society for Microbiology (ASM)

By uniting research from 8 cohorts across the U.S., a group of researchers has accelerated collection of data integral in answering questions about immune responses needed for long lasting protection from SARS-CoV-2.

Newswise: Some people fared better than others during COVID-19 pandemic due to genetics
11-May-2022 4:15 PM EDT
Some people fared better than others during COVID-19 pandemic due to genetics
PLOS

Genetic factors played a greater role in a person's overall wellbeing as the pandemic wore on.

Released: 19-May-2022 9:30 AM EDT
UCSF Awarded $67.5 Million to Develop New Antiviral Therapies
University of California, San Francisco (UCSF)

Scientists at the UC San Francisco (UCSF) Quantitative Biosciences Institute (QBI) and the QBI Coronavirus Research Group (QCRG) have been awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness.

Released: 18-May-2022 5:00 PM EDT
COVID Booster Needed for Broad Protection Against Omicron Variants
Ohio State University

A COVID-19 booster shot will provide strong and broad antibody protection against the range of omicron sublineage variants of the SARS-CoV-2 virus in circulation, two new studies using serum from human blood samples suggest.

Newswise: After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign
Released: 18-May-2022 9:55 AM EDT
After Sprint for COVID-19 Vaccines, HVTN Researchers Return to HIV Marathon With Fresh Determination and Knowledge, Launch Clinical Research Registry and Ad Campaign
HIV Vaccine Trials Network

SEATTLE (May 18, 2022) – Building on momentum from the highly successful COVID-19 vaccine clinical trials, the HIV Vaccine Trials Network (HVTN) is launching a new HIV awareness campaign and unveiling a first-of-its-kind national registry that will provide updated HIV information and make it easier to learn about and participate in HIV clinical trials at HelpEndHIV.org.

Released: 16-May-2022 5:05 PM EDT
Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine, national study finds
Taylor & Francis

The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics.

Released: 16-May-2022 5:05 PM EDT
How common is readmission after hospitalization for COVID-19?
Canadian Medical Association Journal

For patients discharged after hospitalization for COVID-19, death or readmission was common, with about 11% being readmitted or dying within 30 days, according to new research published in CMAJ (Canadian Medical Association Journal)

Released: 13-May-2022 2:45 PM EDT
Monitoring User Opinions and Side Effects on COVID-19 Vaccines in the Twittersphere: Infodemiology Study of Tweets
Journal of Medical Internet Research

Background: In the current phase of the COVID-19 pandemic, we are witnessing the most massive vaccine rollout in human history. Like any other drug, vaccines may cause unexpected side effects, which need to be investigated in a timel...

Newswise: 2022 Warren Alpert Prize goes to mRNA research that enabled the design of COVID-19 vaccines
Released: 12-May-2022 7:30 AM EDT
2022 Warren Alpert Prize goes to mRNA research that enabled the design of COVID-19 vaccines
Harvard Medical School

The work of the award recipients altered the trajectory of the pandemic and has saved countless lives The discoveries made by the five scientists have opened the door for an array of mRNA-based therapies and vaccines for a range of diseases, including cancer, heart disease, bleeding disorders, and more

Newswise: COVID-19 Vaccine Effective in People Receiving Cancer Treatment, Study Finds
Released: 11-May-2022 12:15 PM EDT
COVID-19 Vaccine Effective in People Receiving Cancer Treatment, Study Finds
University of Kansas Cancer Center

About 95% of participants achieved a measurable immune response after vaccination, according to study published in JAMA Oncology.

Released: 11-May-2022 12:00 PM EDT
Short-lived booster effect and stable CD8+ T cell memory after 3rd COVID-19 vaccine dose
Preprints

Robert Thimme, Matthias Reinscheid, Hendrik Luxenburger, Vivien Karl, Anne Graeser, Sebastian Giese, Kevin Ciminski, David Reeg, Valerie Oberhardt, Natascha Röhlen, Julia Lang-Meli, Kathrin Heim, Nina Gross, Christina Baum, Siegbert Rieg, Claudius Speer, Florian Emmerich, Susanne Breisinger, Daniel Steinmann, Bertram Bengsch, Tobias Boettler, Georg Kochs, Martin Schwemmle, Christoph Neumann-Haefelin, Maike Hofmann

Newswise: COVID-19 Severity Influences Preventive Measures More than Fear of Getting It
Released: 10-May-2022 8:30 AM EDT
COVID-19 Severity Influences Preventive Measures More than Fear of Getting It
Florida Atlantic University

A study of 719 members of a public social-media focused group examined various aspects of COVID-19 that included experience, perceptions and prevention aspects. Results revealed that while much of the media and policy makers have promoted the susceptibility of COVID-19 such as the number of cases, this study showed that it is potential severity that has a stronger influence on prevention practices. Increased emphasis on the severity of COVID-19 could lead to increased prevention practices.

   
Released: 6-May-2022 2:10 PM EDT
New research confirms racism in healthcare settings increases vaccine hesitancy among ethnic minority groups
SAGE Publications UK

A new study examining the associations between racial and ethnic discrimination and COVID-19 vaccine refusal has found that one in ten people from ethnic minority groups who refused a vaccine experienced racial discrimination in a medical setting since the start of the pandemic.



close
1.889